IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • MANAS Journal of Engineering
  • Volume:1 Issue:6
  • Development of Nephelometric Α1-At Method and its Performance Characteristics

Development of Nephelometric Α1-At Method and its Performance Characteristics

Authors : M ÇALAPOĞLU, O DEĞER, A ALVER, N Ş ÇALAPOĞLU, E KALAY, C K BURUK
Pages : 29-39
View : 11 | Download : 6
Publication Date : 2005-01-01
Article Type : Research Paper
Abstract :α1-AT, a glycoprotein of molecular mass of 52 kDa, is a major plasma serine protease inhibitor serpin . α1-AT plays a central role as a protease inhibitor in controlling tissue degradation. As a major protease inhibitor in human plasma, α1-AT can complex with a broad spectrum of proteases including elastase, trypsin, chymotrypsin, thrombin, and bacterial leukocyte elastase. α1-AT is an acute phase reactant whose plasma concentration can rise by 3 to 4-fold above normal during inflammation, infection and malignant disease. α1-AT deficiency, one of the most common hereditary disorders, mainly affects the liver and lung [1,2]. The concentrations of α1-AT in plasma can be measured either by functional assays or by immunochemical methods. Functional assays evaluate inhibition of trypsin or elastase. Immunologic methods include radial immunodiffusion, electroimmunoassay and automated nephelometric methods.
Keywords :

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025